MedPath

GILEAD SCIENCES INC

GILEAD SCIENCES INC logo
🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease

Phase 3
Completed
Conditions
Crohn’s Disease
Last Posted Date
2024-08-20
Lead Sponsor
Gilead Sciences, Inc
Registration Number
SLCTR/2019/002
© Copyright 2025. All Rights Reserved by MedPath